Clinical Trials Logo

Clinical Trial Summary

The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be included in the registry to enable future comparisons of treatment outcomes to assist in understanding which patients can benefit from the use of protons.


Clinical Trial Description

Proton based radiation therapy has considerable dosimetric advantages over the standard photon based radiation therapy, with a significantly higher cost. The clinical advantages, however, may not be realized for all patient populations, even with the improved dose distributions. Establishing the clinical efficacy of proton therapy requires years of experience treating patients. The goal is to accelerate the knowledge gain through the use of the registry that allows for detailed information to be captured and is inclusive of every patient treated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04376229
Study type Observational [Patient Registry]
Source Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact Akila Viswanathan, MD
Phone 410-502-1421
Email anv@jhmi.edu
Status Recruiting
Phase
Start date April 7, 2020
Completion date December 2040

See also
  Status Clinical Trial Phase
Completed NCT04563013 - Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients N/A
Recruiting NCT05684367 - Exercise to ReGain Stamina and Energy (The EXERGISE Study) N/A
Recruiting NCT05880160 - Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction N/A
Recruiting NCT04151342 - CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Not yet recruiting NCT05465031 - Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Phase 4
Recruiting NCT05797077 - Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA Phase 3
Not yet recruiting NCT03777930 - The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol Phase 4
Not yet recruiting NCT06376435 - A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia
Completed NCT06268535 - Identification of Anticancer Drugs Associated With Heart Failure: a WHO Pharmacovigilance Database Analysis
Recruiting NCT05151952 - Proton Therapy Medical Registry